Hopps R M, Nuki K, Raisz L G
Calcif Tissue Int. 1980;31(3):239-45. doi: 10.1007/BF02407187.
The bone resorbing activity of suspensions or supernatants of freeze-dried powdered gingiva was studied by measuring the release of 45Ca from prelabeled fetal rat long bones in organ culture. Two preparations of noninflamed attached gingiva showed no bone resorbing activity, whereas all six preparations of inflamed marginal gingiva tested showed a dose-related stimulation of 45Ca release. Evidence of an osteoclastic mechanism was provided by the inhibition of the bone resorbing activity by calcitonin and cortisol and the minimal activity observed on dead bones. The activity was heat stable and not blocked by human serum. Three different prostaglandin synthetase inhibitors did not inhibit the activity. Immunoassay showed that PGE was present in gingival powder preparations at concentrations in the range 229-2438 pg/mg dry weight. This was insufficient to account for the observed bone resorbing activity by a factor of 50-350. It was concluded that in addition to PGE, inflamed gingiva contains other heat-stable bone resorbing factor(s).
通过测量器官培养中预先标记的胎鼠长骨释放的45Ca,研究了冻干牙龈粉悬液或上清液的骨吸收活性。两份非炎症性附着龈制剂未显示出骨吸收活性,而所测试的六份炎症性边缘龈制剂均显示出与剂量相关的45Ca释放刺激作用。降钙素和皮质醇对骨吸收活性的抑制以及在死骨上观察到的最小活性提供了破骨细胞机制的证据。该活性对热稳定且不受人血清的阻断。三种不同的前列腺素合成酶抑制剂并未抑制该活性。免疫测定显示,牙龈粉制剂中PGE的浓度范围为229 - 2438 pg/mg干重。这不足以解释所观察到的骨吸收活性,相差50 - 350倍。得出的结论是,除了PGE外,炎症性牙龈还含有其他热稳定的骨吸收因子。